Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve

Archives of Ophthalmology

Volumn 116, Issue 7, 1998, Pages 906-910

  Yoles, Eti ^a   Schwartz, Michal ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID;

AMINO ACID COMPOSITION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; NERVE CRUSH; NERVE DEGENERATION; NONHUMAN; OPTIC NERVE DISEASE; OPTIC NERVE LESION; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL;

EID: 0031789649     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.7.906     Document Type: Article

References (42)

1. Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol. 1983;118:166-191.
2. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774-786.
3. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma, II: the site of injury and susceptibility to damage. Am J Ophthalmol. 1981;99:635-649.
4. Perkins ES. The Bedford glaucoma survey, I: long-term follow-up of borderline cases. Br J Ophthalmol. 1975;57:179-185.
5. Brubaker RF. Delayed functional loss in glaucoma: LII Edward Jackson Memorial Lecture. Am J Ophthalmol. 1996;121:473-483.
6. Fechtner RD, Weinreb RPJ. Mechanisms of optic nerve damage in primary open-angle glaucoma. Surv Ophthalmol. 1994;39:23-42.
7. Sommer A, Katz J, Quigley HA, Miller MR, Robin AL, Richter RC. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109:77-83.
8. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open-angle glaucoma among white and black Americans. Arch Ophthalmol. 1991;109:1090-1095.
9. Schumer RA, Podos SM. The nerve of glaucomal Arch Ophthalmol. 1994;112:37-44.
10. Faden AI. Pharmacotherapy in spinal cord injury: a critical review of recent developments. Clin Neuropharmacol. 1987;10:193-204.
11. Faden Al, Salzman S. Pharmacological strategies in CNS trauma. Trends Pharmacol Sci. 1992;13:29-35.
12. Garcia-Valenzuela E, Gorczyca W, Darzynkiewicz Z, Sharma S. Apoptosis in adult retinal ganglion cells after axotomy. J Neurobiol. 1993;25:431-438.
13. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114:299-305.
14. Assia E, Rosner M, Belkin M, Schwartz M. Temporal parameters and low-energy laser irradiation for optimal delay of posttraumatic degeneration of rat optic nerve. Brain Res. 1989;476:205-212.
15. Duvdevani R, Rosner M, Belkin M, Sautter J, Sabel BA, Schwartz M. Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome. Restor Neurol Neurosci. 1990;2:31-38.
16. Yoles E, Zalish M, Lavie V, Duvdevani R, Ben-Bassat S, Schwartz M. GM, reduces early injury-induced metabolic deficits and subsequent degeneration in the rat optic nerve. Invest Ophthalmol Vis Sci. 1992;83:3586-3591.
17. Yoles E, Belkin M, Schwartz M. HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy. J Neurotrauma. 1996;13:49-57.
18. Yoles E, Muller S, Schwartz M. NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush. J Neurotrauma. 1997;14:665-675.
19. Yoles E, Schwartz M. Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp Neurol. In press.
20. Choi DA. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623-634.
21. Choi DW. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Anna Rev Neurosci. 1990;13:171-182.
22. Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch Ophthalmol. 1957;58:193-201.
23. Olney JW. Glutamate-induced retinal degeneration in neonatal mice: electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol. 1969;28:455-474.
24. Sucher NJ, Lei SZ, Lipton SA. Calcium channel antagonists attenuate NMDA receptor mediated neurotoxicity of retinal ganglion cells in culture. Brain Res. 1991;551:297-302.
25. Dreyer EB, Pan ZH, Storm S, Lipton SA. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. Neuroreport. 1994;5:629-631.
26. Perez MT, Arner K, Hakansson A. DNA fragmentation characteristic of apoptosis and cell loss induced by kainic acid in rabbit retinas. Neurochem Int. 1997;31:251-260.
27. Misantone LJ, Gershenbaum M, Murray M. Viability of retinal ganglion cells after optic nerve crush in adult rats. J Neurocytol. 1984;13:449-465.
28. Barren KD, Detinger MP, Grohel G, Easton SK, Mankes R. Qualitative and quantitative ultrastructural observations on retinal ganglion cell layer of rat after intraorbital optic nerve crush. J Neurocytol. 1986;15:345-362.
29. Panzanelli P, Cantino D, Sassoe-Pognetto M. Co-localization of carnosine and glutamate in photoreceptors and bipolar cells of the frog retina. Brain Res. 1997;758:143-152.
30. Jojich L, Pourcho RG. Glutamate immunoreactivity in the cat retina: a quantitative study. Vis Neurosci. 1996;13:117-133.
31. Derouiche A. Possible role of the Mueller cell in uptake and metabolism of glutamate in the mammalian outer retina. Vision Res. 1996;36:3875-3878.
32. Rauen T, Rothstein JD, Wassle H. Differential expression of three glutamate transporter subtypes in the rat retina. Cell Tissue Res. 1996;286:325-336.
33. Agostinho P, Duarte CB, Oliveira CR. Impairment of excitatory amino acid transporter activity by oxidative stress conditions in retinal cells: effect of antioxidants. FASEB J. 1997;11:154-163.
34. Billups B, Attwell D. Modulation of non-vesicular glutamate release by pH. Nature. 1996;379:171-174.
35. Rego AC, Santos MS, Oliveria CR. Oxidative stress, hypoxia, and ischemia-like conditions increase the release of endogenous amino acids by distinct mechanisms in cultured retinal cells. J Neurochem. 1996;66:2506-2516.
36. Agostinho P, Duarte CB, Carvalho AP, Oliveira CR. Oxidative stress affects the selective ion permeability of voltage-sensitive Ca2+ channels in cultured retinal cells. Neurosci Res. 1997;27:323-334.
37. Duarte CB, Santos PF, Sanchez-Prieto J, Carvalho AP. Glutamate release evoked by glutamate receptor agonists in cultured chick retina cells: modulation by arachidonicacid. J Neurosci Res. 1996;44:363-373.
38. 3H]D-aspartate from cultured chick retina cells. Neurochem Res. 1996;21:361-368.
39. Solberg Y, Rosner M, Turetz J, Belkin M. MK-801 has neuroprotective and antiproliferative effects in retinal laser injury. Invest Ophthalmol Vis Sci. 1997;38:1380-1389.
40. Brooks DE, Garcia GA, Dreyer EB, Zurakowski D, Franco-Bourland RE. Vitreous body glutamate concentration in dogs with glaucoma. Am J Vet Res. 1997;58:864-867.
41. Ambati J, Chalam KV, Chawala DK, et al. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol. 1997;115:1161-1166.
42. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB. Chronic low-dose glutamate is toxic to retinal ganglion cells. Invest Ophthalmol Vis Sci. 1996;37:1618-1624.